Frontiers in Pharmacology (Oct 2022)
Corrigendum: Evaluation of herb–drug interaction between Danshen and rivaroxaban in rat and human liver microsomes
- Xu Wang,
- Jingjing Fa,
- Yuanjin Zhang,
- Shengbo Huang,
- Jie Liu,
- Junqing Gao,
- Lina Xing,
- Lina Xing,
- Zongjun Liu,
- Zongjun Liu,
- Xin Wang
Affiliations
- Xu Wang
- Department of Cardiology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China
- Jingjing Fa
- Department of Cardiology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China
- Yuanjin Zhang
- Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences, School of Life Sciences, East China Normal University, Shanghai, China
- Shengbo Huang
- Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences, School of Life Sciences, East China Normal University, Shanghai, China
- Jie Liu
- Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences, School of Life Sciences, East China Normal University, Shanghai, China
- Junqing Gao
- Department of Cardiology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China
- Lina Xing
- Department of Cardiology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China
- Lina Xing
- Putuo Clinical Medical School, Anhui Medical University, Shanghai, China
- Zongjun Liu
- Department of Cardiology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China
- Zongjun Liu
- Putuo Clinical Medical School, Anhui Medical University, Shanghai, China
- Xin Wang
- Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences, School of Life Sciences, East China Normal University, Shanghai, China
- DOI
- https://doi.org/10.3389/fphar.2022.1039267
- Journal volume & issue
-
Vol. 13
Abstract
No abstracts available.Keywords
